Skip to content

A prospective randomized single-blind control study of volume threshold for chest tube removal following lobectomy

A prospective randomized single-blind control study of volume threshold for chest tube removal following lobectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12003413
Enrollment
Unknown
Registered
2012-04-03
Start date
2012-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early removal of the chest tube following lobectomy

Interventions

early removal group:removal of chest tube at the level of 300 ml/24h
traditional management group:traditional management, removal of chest tube at the level of 100 ml/24h

Sponsors

Department of Thoracic Surgery, Beijing Chao-yang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. All patients undergoing a c-VATS (bi-)lobectomy or an open thoracotomy; 2. Without cruor function; 3. Without hypoproteinemia before and after the operation; 4. Absence of extensive adhesions or visceral pleural disruption; 5. No postoperative hemorrhage.

Exclusion criteria

Exclusion criteria: 1. lobectomies with chest wall resections; 2. intrapericardial resections; 3. those with heart failure, nephritic syndrome, chronic renal failure and cirrhosis; 4. patients in whom the surgeon expected increased postoperative hemorrhage, such as hematological system diseases and pleural extensive adhesion; 5. prolonged air leak (air leakage that lasted more than 6 days was considered prolonged air leakage); 6. a densely bloody, purulent, or cloudy pleural effusion; 7. adverse cardiovascular and cerebrovascular events.

Design outcomes

Primary

MeasureTime frame
the volume of drainage;the character of drainage;test of chest drainage;postoperative complications;Post-operative hospital stay;

Secondary

MeasureTime frame
Drainage time;Thoracentesis;

Countries

China

Contacts

Public ContactLI Hui
huilee@vip.sina.com+86 13701158350

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026